Quick Answer
OCULAR THERAPEUTIX, INC reported Revenue (ASC 606) of $51.95 million for fiscal year 2025.
OCULAR THERAPEUTIX, INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $51.95M | -18.5% |
| 2024 | $63.72M | +9.0% |
| 2023 | $58.44M | +13.5% |
| 2022 | $51.49M | +18.3% |
| 2021 | $43.52M | +150.1% |
| 2020 | $17.40M | +311.7% |
| 2019 | $4.23M | +112.4% |
| 2018 | $1.99M | +3.5% |
| 2017 | $1.92M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.54M | -5.7% | +8.1% |
| June 30, 2025 | $13.46M | -18.1% | +25.8% |
| March 31, 2025 | $10.70M | -27.6% | -30.6% |
| September 30, 2024 | $15.43M | +2.3% | -6.2% |
| June 30, 2024 | $16.44M | +8.3% | +11.3% |
| March 31, 2024 | $14.77M | +10.5% | -2.0% |
| September 30, 2023 | $15.08M | +26.0% | -0.7% |
| June 30, 2023 | $15.19M | +23.8% | +13.5% |
- OCULAR THERAPEUTIX, INC showed a decrease of -18.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, OCULAR THERAPEUTIX, INC’s revenue (asc 606) has grown by 2601.6% (from $1.92 million to $51.95 million).
- The most recent figure is from OCULAR THERAPEUTIX, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: